Investigating cannabis use in patients with lung cancer and multiple myeloma during treatment
A Prospective Cohort Study of Patients with Non-Small Cell Lung Cancer and Multiple Myeloma to Assess the Benefits and Harms Related to Cannabis Use During Treatment
This study is looking at how people with non-small cell lung cancer and multiple myeloma use cannabis while getting treatment, and it wants to understand how they talk about it with their doctors, so we can learn more about the benefits and risks of cannabis for these patients.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beckman Research Institute/city of Hope NIH-funded |
| Lab location | 1 site (Duarte, United States) |
| Project ID | NIH-10932378 on NIH RePORTER |
What this research studies
This research examines how patients with non-small cell lung cancer and multiple myeloma use cannabis while undergoing treatment. It aims to gather information on the prevalence and patterns of cannabis use among these patients, as well as how they communicate about cannabis with their healthcare providers. By addressing the knowledge gap regarding the efficacy and potential side effects of cannabis, the study seeks to provide valuable insights for both patients and clinicians. Participants will be monitored over time to assess the benefits and harms associated with cannabis use during their cancer treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with non-small cell lung cancer or multiple myeloma who are currently undergoing treatment.
Not a fit: Patients with other types of cancer or those not currently receiving treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could help clarify the effects of cannabis on cancer treatment, potentially leading to better-informed decisions for patients.
How similar studies have performed: While there is growing interest in the use of cannabis among cancer patients, this specific approach to studying its effects during treatment is relatively novel and has not been extensively tested.
Where this research is happening
Duarte, United States
- Beckman Research Institute/city of Hope — Duarte, United States (Active)
Researchers
- Principal investigator: Lee, Richard T — Beckman Research Institute/city of Hope
- Study coordinator: Lee, Richard T
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.